Jeisys Density

Monopolar RF Tightening · High-intensity monopolar RF (Thermage rival)

CurrentFDA ClearedBe the first to review

What it's actually cleared for: Monopolar RF cleared for electrocoagulation and hemostasis in dermatologic/general surgery — no specific tightening indication

Last verified: August 6, 2026 · How we verify

New: —|Used: $15k–$30kmarket estimate, no email required

Save device

Bottom line

Jeisys's direct run at Thermage FLX — a no-needle, no-downtime monopolar RF tightening device from the same Korean manufacturer that builds Cynosure's Potenza, sold in the US through Jeisys Medical North America. The pitch: sequential monopolar-plus-bipolar RF in one pulse at device and consumable costs meaningfully below Thermage, letting you sell a Thermage-class treatment at a friendlier price. The catch is brand: patients search "Thermage," not "Density" — you'll market the outcome. US service infrastructure is still being proven; factor that into negotiation.

Overview

Korean Thermage competitor entering Western markets

How it works

The science

Monopolar RF drives energy deep into the dermis and subcutaneous fibrous septae (return pad completes the circuit): bulk volumetric heating, immediate collagen contraction, months of neocollagenesis for face and body laxity. Density's twist: monopolar and bipolar RF delivered sequentially within a single pulse, which Jeisys claims yields substantially more collagen stimulation than monopolar alone. Integrated contact cooling; one to two treatments spaced 4-6 months; results build 2-6 months.

Patented tech

Sequential monopolar+bipolar delivery, Smart Adjustable Cooling (five levels), Real-Time Auto Calibration adjusting energy against tissue feedback — functionally an impedance-based auto-dosing system similar in concept to Thermage's AccuREP.

Origin

Seoul, South Korea (Jeisys Medical — the OEM behind Cynosure's Potenza); US ops via Jeisys Medical North America (Burlington, MA).

FDA & regulatory status

FDA ClearedCleared via 510(k)

What it's actually cleared for:

Monopolar RF cleared for electrocoagulation and hemostasis in dermatologic/general surgery — no specific tightening indication

510(k) numbers

K230663; K250065

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

Full-face/neck $1,200-2,500 — deliberately undercutting Thermage FLX's typical $2,500-4,500 — with body zones priced similarly. Single-session-with-annual-maintenance model.

Consumables & recurring cost

Like Thermage, single-use tips with fixed shot counts; per-treatment tip cost reported below Thermage's $600-900+ but exact US pricing varies — verify with Jeisys. 4-6 treatments weekly still means tens of thousands annually in tips.

Ideal for

Best-fit practice

Practices losing tightening patients to Thermage providers who want that revenue at lower entry cost, or Potenza owners who trust the Jeisys build. Patients 40-65, mild-moderate laxity, needle-averse, zero downtime, $1,500+ once-a-year treatment.

Compliance

Medical director & delegation

Class II electrosurgical device requiring physician oversight in most states; commonly delegated to RNs/NPs after manufacturer training — verify locally.

Contraindications & screening

Pacemakers/defibrillators and implanted electronics are the hard stop for monopolar RF; also metal implants near the area, pregnancy, active skin disease at the site.

Ownership

Warranty & service

~1-year standard typical for new US entrants, extended negotiable — get terms in writing and pressure-test the young North America service bench (loaner policy, phone support).

Resale & used market

Essentially no US secondary market yet — no used-price erosion to point to, but no proven exit either; expect Korean-brand discounting steeper than Thermage's once units circulate.